中国实用内科杂志Pub Date : 2020-01-01DOI: 10.19538/j.nk2020080102
Bo Wang
{"title":"Laboratory diagnosis of the etiology of viral infectious diseases","authors":"Bo Wang","doi":"10.19538/j.nk2020080102","DOIUrl":"https://doi.org/10.19538/j.nk2020080102","url":null,"abstract":"It must grow the awareness that contagious have never been far away from mankind. and the threats have always been next to us. Taking the laboratory detections of severe acute respiratmy syndrome coronavirus 2 (SARS-CoV-Z) as an example, this article mainly introduces the advantages and limitations of the I'eaJ-time fluorescent quantitative PCR and serological antibody detection teehnnlogy that 11an been used for laboratory detections of the etiology of Viral infectious diseases. It is hoped that the intmduetion will be helpful to the clinical diagnosis of viral infectious diseases, espet'ially COVID~19.","PeriodicalId":10176,"journal":{"name":"中国实用内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68153300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中国实用内科杂志Pub Date : 2011-01-01DOI: 10.4103/2224-4018.124276
Wang Ying-qia
{"title":"Senile hypopituitarism:characteristics of diagnosis and treatment","authors":"Wang Ying-qia","doi":"10.4103/2224-4018.124276","DOIUrl":"https://doi.org/10.4103/2224-4018.124276","url":null,"abstract":"Hypopituitarism is a clinical syndrome caused by reduced production of adenohypophyseal hormones.Senile hypopituitarism may show a much more complicated picture of clinical manifestations,and a delay in diagnosis and treatment may lead to rapid development of pituitary crisis.Therefore,clinicians should be alerted for senile hypopituitarism.For patients with hyponatremia,hypoglycemia and unexplained coma,an evaluation of pituitary function should be performed.Patients with confirmed hypopituitarism should remain on regular hormone replacement therapy(HRT) and are absolutely not allowed for self-initiated tapering or discontinuation of medications.","PeriodicalId":10176,"journal":{"name":"中国实用内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70256467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中国实用内科杂志Pub Date : 2011-01-01DOI: 10.4103/2224-4018.124280
T. Hu
{"title":"Senile parathyroid dysfunction:characteristics of diagnosis and treatment","authors":"T. Hu","doi":"10.4103/2224-4018.124280","DOIUrl":"https://doi.org/10.4103/2224-4018.124280","url":null,"abstract":"Senile parathyroid dysfunction is mainly seen in primary or secondary hyperparathyroidism(PHPT or SHPT).PHPT in the elderly usually affects in females,with fatigue and osteoporosis as the common symptoms.Screening of blood calcium and further evaluation of parathyroid hormone(PTH) for subjects with blood calcium 2.6mmol/l can be helpful for early identification of patients.For PHPT patients who are indicated for surgery and whose lesion can be well localized,surgical treatment can be more beneficial.SHPT is mainly found in patients with end-stage chronic renal dysfunction necessitating hemodialysis or peritoneal dialysis.For these patients,monitoring of PTH level,early supplement of calcium preparations and use of large-dose calcitriol appears helpful to maintain the blood levels of calcium and PTH.","PeriodicalId":10176,"journal":{"name":"中国实用内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70256522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中国实用内科杂志Pub Date : 2008-11-16DOI: 10.1182/BLOOD.V112.11.5211.5211
Juan Li, Ying Zhao
{"title":"Clinical Experience and Prognostic Factors with Bortezomib-Combined Regimen in 40 Patients with Multiple Myeloma","authors":"Juan Li, Ying Zhao","doi":"10.1182/BLOOD.V112.11.5211.5211","DOIUrl":"https://doi.org/10.1182/BLOOD.V112.11.5211.5211","url":null,"abstract":"To explore the medical effects, prognostic factors relating to the effects and side effects of bortezomib-combined regimen in treatment of multiple myeloma (MM), and evaluate the safety of this regimen in patients with special conditions. Methods: Forty newly diagnosed and relapsed or refractory MM treated with the regimen of combination of bortezomib and dexamethasone in a cycle of 3 weeks. All of the patients received a median of 3 (1–9) cycles of the treatment. Response to bortezomib was evaluated according to the criteria of the European Group for Blood and Marrow Transplantation (EBMT) and adverse events were graded according to the National Cancer Institute Common Toxicity Criteria. Results: Total response rate was 75.0% (30/40), and the rate of CR+nCR was 42.5% (17/40). Eighty percent patients (24/30) showed effects after the first cycle, although the median time of best effect was 2 cycles. Compare to the other types, light-chain type had higher total response rate (100.0% vs. 65.5%, P=0.038)and CR rate (36.4% vs. 6.9%, P=0.039), and also responded earlier with 81.8% (9/11) patients reached the best effect after the first cycle. The factors which showed no relationship to the effects were age ( 65 years, P=0.081), sex (P=0.696), DS staging (P=1.0), ISS staging(P=0.969), newly or retreated (P=0.731), using thalidomide or not(P=0.338), renal function damage or not(P=0.401), PLT level(P=1.0), hypercalcemia or not(P=0.306), Hb level(P=0.70)and the ratio of tumor cells in bone marrow(P=0.693). Grade III~IV adverse effects in this VD regimen was low, including leucocytopenia, thrombocytopenia, diarrh ea and debility, could be relieved by symptomatic treatment or delay the chemotherapy. The rate of infection was high and which was one of the important cause of death. Renal function improvement could be showed in all of the 10 patients who had renal inadequacy, and compared with normal patients, the incidences of side and adverse effects had no statistical differences. Conclusion: The Bortezomib combination regimen has significant effect in MM treatment. It shows more significant in light-chain type patients, and show earlier effect onset. This regimen can be tolerant in most patients, and is also safe in patients with renal inadequacy.","PeriodicalId":10176,"journal":{"name":"中国实用内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2008-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65808749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中国实用内科杂志Pub Date : 2006-03-20DOI: 10.3760/CMA.J.ISSN.1673-4157.2006.02.001
G. Xi
{"title":"Nonalcoholic fatty liver disease and metabolic syndrome","authors":"G. Xi","doi":"10.3760/CMA.J.ISSN.1673-4157.2006.02.001","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1673-4157.2006.02.001","url":null,"abstract":"Nonalcoholic fatty liver disease(NAFLD)comprises a disease spectrum which includes variable degrees of simple steatosis nonalcoholic steatohepatitis(NASH) and cirrhosis even liver failure and patocellular carcinoma.NAFLD can be considered the hepatic manifestation of the metabolic syndrome and is an independent predictor of type 2 diabetes(T2DM) and cardiovascular disease(CVD).Insulin resistance is the pathogenetic link between the metabolic syndrome and fat accumulation in the liver.Patients with NAFLD are a high risk population of the both of diseases.It's very important significance to early diagnosis and treatment of NAFLD for prevention T2DM and CVD.","PeriodicalId":10176,"journal":{"name":"中国实用内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2006-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70099094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}